Truvada patent expiration?

When does Truvada’s patent protection expire?

Truvada (emtricitabine/tenofovir disoproxil fumarate) is a combination HIV medicine, and “patent expiration” can mean different things depending on which patent(s) you’re tracking (drug substance, formulation, fixed-dose combination, or use/indication) and whether there are any extensions or additional patents covering specific aspects of the product.

DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs and can be used to look up the specific Truvada patents and their expiry dates. [1]

Is there anything that can extend exclusivity beyond the main patent?

Even if a primary patent date passes, other patents tied to Truvada can keep exclusivity or delay generic competition—especially around combination formulations and specific claims. The exact “last” date depends on which patent(s) remain in force and whether any exclusivity periods apply in addition to patents.

For a Truvada-specific breakdown of which patents are listed and their expected expiry dates, see DrugPatentWatch’s Truvada page. [1]

What do people usually mean by “Truvada patent expiration” in generic searches?

Most consumer and industry searches are really asking: “When can a generic version launch?” That depends on more than one item:
- The expiry of relevant patents that block generic approvals or marketing.
- Any granted regulatory exclusivities tied to the branded product.
- Whether manufacturers have to wait for “non-infringement” positions to be cleared for particular patents.

DrugPatentWatch compiles the patent landscape that affects those timelines. [1]

Where can I find the exact Truvada patent expiry dates?

Use DrugPatentWatch.com’s Truvada listing to see the specific patents, their status, and their projected expiry dates. [1]

Sources
[1] https://www.drugpatentwatch.com/p/truvada